Survivin promotes the invasion of human colon carcinoma cells by regulating the expression of MMP-7

Molecular Medicine Reports

Volumn 9, Issue 3, 2014, Pages 825-830

  Gao, Fei ^a,c   Zhang, Yuqin ^a   Yang, Feng ^b   Wang, Peng ^d   Wang, Wenjun ^a   Su, Yan ^a   Luo, Weiren ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^d GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Colon carcinoma; Invasion; MMP 7; Survivin

Indexed keywords

CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MATRIX METALLOPROTEINASE 7; RNA INTERFERENCE; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84893849200     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1897     Document Type: Article

References (28)

1. Mita AC, Mita MM, Nawrocki ST and Giles FJ: Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 14: 5000-5005, 2008.
2. McKenzie JA, Liu T, Goodson AG and Grossman D: Survivin enhances motility of melanoma cells by supporting Akt activation and α5 integrin upregulation. Cancer Res 70: 7927-7937, 2010.
3. Zhang M, Coen JJ, Suzuki Y, et al: Survivin is a potential mediator of prostate cancer metastasis. Int J Radiat Oncol Biol Phys 78: 1095-1103, 2010.
4. Abdraboh ME, Gaur RL, Hollenbach AD, Sandquist D, Raj MH and Ouhtit A: Survivin is a novel target of CD44-promoted breast tumor invasion. Am J Pathol 179: 555-563, 2011.
5. Zhonghong L, Lianjie L, Changqing Z, Ying H, Yu J and Yan L: The influence of survivin shRNA on the cell cycle and the invasion of SW480 cells of colorectal carcinoma. J Exp Clin Cancer Res 27: 20, 2008.
6. Chu XY, Chen LB, Wang JH, et al: Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer. J Surg Oncol 105: 520-528. 2012.
7. Chen P and Parks WC: Role of matrix metalloproteinases in epithelial migration. J Cell Biochem 108: 1233-1243, 2009.
8. Ii M, Yamamoto H, Adachi Y, Maruyama Y and Shinomura Y: Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 231: 20-27, 2006.
9. Wang FQ, So J, Reierstad S and Fishman DA: Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int J Cancer 114: 19-31, 2005
10. Lynch CC, Hikosaka A, Acuff HB, et al: MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 7: 485-496, 2005.
11. Shi M, Liu D, Duan H, et al: Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer. Mol Cancer 9: 269, 2010.
12. Sizemore ST and Keri RA: The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression. J Biol Chem 287: 24631-24640, 2012.
13. Miyamoto S, Yano K, Sugimoto S, et al: Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein. Cancer Res 64: 665-671, 2004
14. Ho BY, Wu YM, Chang KJ and Pan TM: Dimerumic acid inhibits SW620 cell invasion by attenuating H2O2-mediated MMP-7 expression via JNK/C-Jun and ERK/C-Fos activation in an AP-1-dependent manner. Int J Biol Sci 7: 869-880, 2011.
15. Lee SK, Han YM, Yun J, et al: Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells. Int J Cancer 131: E190-E203, 2012.
16. Wang WS, Chen PM, Wang HS, Liang WY and Su Y: Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma. Carcinogenesis 27: 1113-1120, 2006.
17. Koskensalo S, Louhimo J, Nordling S, Hagström J and Haglund C: MMP-7 as a prognostic marker in colorectal cancer. Tumour Biol 32: 259-264, 2011.
18. Fang YJ, Lu ZH, Wang GQ, et al: Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int J Colorectal Dis 24: 875-884, 2009.
19. Wang GQ, Lu ZH, Fang YJ, Chen G, Zhou ZW, Pan ZZ and Wan DS: Expression and clinical significance of survivin and matrix metalloproteinase-7 in colon cancer. Ai Zheng 28: 945-949, 2009 (In Chinese).
20. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
21. Kelley RK, Wang G and Venook AP: Biomarker use in colorectal cancer therapy. J Natl Compr Canc Netw 9:1293-1302, 2011.
22. Altieri DC: Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8: 61-70, 2008.
23. Erkanli S, Bolat F, Kayaselcuk F, Demirhan B and Kuscu E: COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma. Gynecol Oncol 104: 320-325, 2007.
24. Pennati M, Folini M and Zaffaroni N: Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis 28: 1133-1139, 2007.
25. Wu JB, Nan QZ, Ma GF, et al: Short hairpin RNA-mediated survivin gene silencing inhibits invasion and metastasis of human colon carcinoma cell line SW480 in vitro. Nan Fang Yi Ke Da Xue Xue Bao 27: 951-954, 2007 (In Chinese).
26. Church DN and Talbot DC: Survivin in solid tumors: rationale for development of inhibitors. Curr Oncol Rep 14: 120-128, 2012.
27. Altieri DC: Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22: 8581-8589, 2003.
28. Kelly RJ, Lopez-Chavez A, Citrin D, Janik JE and Morris JC: Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin. Mol Cancer 10: 35, 2011.